Therapy News and Research

RSS

Study shows that 140 million American adults recommended for behavioral weight-loss treatment

New research shows that 140 million American adults - about 65 percent - are recommended for behavioral weight-loss treatment, with 83% of those (or 116 million) considered for pharmacotherapy.

4 Nov 2014

Resilience training program may help ICU nurses better handle stressful work environment

A multifaceted approach to teaching coping mechanisms may help critical care nurses better handle their stressful work environment, according to a study in the November issue of American Journal of Critical Care (AJCC).

4 Nov 2014

AstraZeneca, Pharmacyclics partner to evaluate efficacy of IMBRUVICA for solid tumors

AstraZeneca and Pharmacyclics, Inc. today announced that they have entered into a clinical trial collaboration to evaluate a novel combination therapy targeting solid tumors.

4 Nov 2014

Astellas, Dana-Farber to develop K-Ras inhibitors for treatment of lung, pancreatic cancers

Dana-Farber Cancer Institute (Dana-Farber) and Astellas Pharma Inc. today announced a three-year collaboration to research and develop small molecule inhibitors of oncogenic K-Ras for the treatment of cancer, including lung cancer.

4 Nov 2014

MSD announces Phase 2b results of doravirine therapy in untreated patients with HIV-1 infection

Merck Sharp & Dohme Ltd. MSD (known as Merck & Co., Inc. in the United States and Canada), today announced the presentation of results from a Phase 2b clinical trial evaluating the safety and efficacy of once daily oral doravirine, an investigational next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI), plus tenofovir/emtricitabine (TDF/FTC) compared to efavirenz plus TDF/FTC in previously untreated patients with HIV-1 infection.

4 Nov 2014

Hospice of the Western Reserve honors more than 2,000 veterans in 2014

Americans across the country will observe Veterans Day on November 11, a special day to salute the men and women who have bravely served our country.

4 Nov 2014

New dialysis decision aid can benefit patients with kidney failure

A KIDNEY dialysis decision aid, enabling patients with decreasing kidney function to better assess which treatment is right for them, has been developed by Kidney Research UK as part of a study in which Sheffield Teaching Hospitals NHS Foundation Trust was involved.

4 Nov 2014

CytRx provides overview of clinical development programs, reports 2014 Q3 financial results

CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today reported financial results for the three months ended September 30, 2014, and also provided an overview of recent accomplishments by and upcoming milestones for its clinical development programs.

4 Nov 2014

UC Davis researchers link increased body fat and lethal drug reactions in mice

Immunotherapy that can be effective against tumors in young, thin mice can be lethal to obese ones, a new study by UC Davis researchers has found. The findings, published online today in The Journal of Experimental Medicine, suggest a possible link between body fat and the risk of toxicity from some types of immunotherapy.

3 Nov 2014

Epicure project: an interview with Frédéric Cren

Epicure is a project led by Inventiva and Institut Curie that aims to deliver pre-clinical candidates on two novel epigenetic targets that have been selected due to their potential to activate immune responses against cancer cells. In addition one of these two targets has potential in respiratory indications such as asthma or COPD.

3 Nov 2014

Novo Nordisk introduces NovoRapid PumpCart insulin pump

Today, Novo Nordisk launches NovoRapid PumpCart, the first prefilled pump cartridge with an insulin analogue that has been specifically designed for insulin pumps. This new treatment solution, which contains NovoRapid (insulin aspart) – a rapid-acting insulin from Novo Nordisk – is expected to make insulin pump therapy more convenient for people with diabetes and their care staff.

From Novo Nordisk 3 Nov 2014

APBI with proton therapy less costly than other traditional treatments for early stage breast cancer

In terms of duration of treatment and cost, patients with early stage breast cancer may benefit from accelerated partial breast irradiation (APBI) with proton therapy versus whole breast irradiation (WBI), according to new research from The University of Texas MD Anderson Proton Therapy Center.

3 Nov 2014

Diabetes treatment with low-cost generic drug can have positive implications for patient's quality of life

New research from CVS Health finds starting a new diabetes patient on metformin, a generic oral diabetes medicine that helps control blood sugar levels, reduced the need to add on additional treatments to control the condition over time. Although there are many classes of oral diabetes medications, there has historically been little evidence available on the comparative effectiveness of treatments to help patients and providers select an initial diabetes therapy.

31 Oct 2014

LAMA/LABA combination better than monotherapy for severe COPD

Combination treatment with umeclidinium bromide and vilanterol offers clinically meaningful improvements over tiotropium monotherapy for patients with moderate-to-very severe chronic obstructive pulmonary disease, study data show.

31 Oct 2014

Combination therapy beneficial for COPD patients

Research published in JAMA supports the use of a combination of long-acting β-agonists and inhaled corticosteroids in patients with chronic obstructive pulmonary disease.

31 Oct 2014

Family therapy useful in bipolar disorder

Psychoeducational family intervention improves social functioning in patients with bipolar I disorder and reduces burden among close relatives, Italian study data show.

31 Oct 2014

Data reveals sustained local control for early stage lung cancer patients who receive SBRT

Analysis of data from an institutional patient registry on stereotactic body radiotherapy (SBRT) indicates excellent long-term, local control, 79 percent of tumors, for medically inoperable, early stage lung cancer patients treated with SBRT from 2003 to 2012, according to research presented today at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology.

31 Oct 2014

Study estimates Medicare costs of lung cancer diagnostic workup in patients

Biopsies were found to be the most costly tool prescribed in lung cancer diagnosis, according to research presented today at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology.

31 Oct 2014

PORT can improve survival for non-small cell lung cancer patients

Patients who received post-operative radiation therapy (PORT), radiation therapy after surgery, lived an average of four months longer when compared to the patients who had the same disease site, tumor histology and treatment criteria and who did not receive PORT, according to research presented today at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology.

31 Oct 2014

New Clinical Practice Guideline for diagnosis, treatment of acromegaly

The Endocrine Society today issued a Clinical Practice Guideline (CPG) for the diagnosis and treatment of acromegaly, a rare condition caused by excess growth hormone in the blood.

31 Oct 2014

Therapy News and Research

Study shows that 140 million American adults recommended for behavioral weight-loss treatment

Resilience training program may help ICU nurses better handle stressful work environment

AstraZeneca, Pharmacyclics partner to evaluate efficacy of IMBRUVICA for solid tumors

Astellas, Dana-Farber to develop K-Ras inhibitors for treatment of lung, pancreatic cancers

MSD announces Phase 2b results of doravirine therapy in untreated patients with HIV-1 infection

Hospice of the Western Reserve honors more than 2,000 veterans in 2014

New dialysis decision aid can benefit patients with kidney failure

CytRx provides overview of clinical development programs, reports 2014 Q3 financial results

UC Davis researchers link increased body fat and lethal drug reactions in mice

Epicure project: an interview with Frédéric Cren

Novo Nordisk introduces NovoRapid PumpCart insulin pump

APBI with proton therapy less costly than other traditional treatments for early stage breast cancer

Diabetes treatment with low-cost generic drug can have positive implications for patient's quality of life

LAMA/LABA combination better than monotherapy for severe COPD

Combination therapy beneficial for COPD patients

Family therapy useful in bipolar disorder

Data reveals sustained local control for early stage lung cancer patients who receive SBRT

Study estimates Medicare costs of lung cancer diagnostic workup in patients

PORT can improve survival for non-small cell lung cancer patients

New Clinical Practice Guideline for diagnosis, treatment of acromegaly

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News